WDL1 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Development and Validation

While specific commercial WDL1 antibodies are not explicitly detailed in the provided sources, typical antibody development strategies for plant proteins include:

  • Immunogen Design: Peptides derived from conserved regions (e.g., residues 1–110 of WDL1).

  • Validation: Western blot, RT-PCR, and immunohistochemistry (IHC) to confirm specificity .

Example Validation Data:

TechniqueTarget TissueResultSource
RT-PCRArabidopsis seedlingsDetected in roots, cotyledons, and shoots
Northern blotFlowers, leavesExpressed in most organs

Protein Localization

  • Immunohistochemistry (IHC): Used to map WDL1 expression in plant tissues (e.g., root tips, vascular bundles) .

  • Subcellular Staining: Detects WDL1 in cell membranes or cytosolic compartments .

Functional Studies

  • Mutant Analysis: Compare WDL1 levels in wild-type vs. wdl1 mutants to assess phenotypic impacts (e.g., cell elongation defects) .

  • Protein-Protein Interactions: Co-immunoprecipitation (Co-IP) to identify binding partners .

Quantitative Analysis

  • Western Blot: Detects ~32 kDa band in Arabidopsis lysates . Optimized secondary antibodies (e.g., HRP-conjugated) enhance sensitivity .

Challenges and Considerations

  • Cross-Reactivity: Antibodies may recognize homologous proteins (e.g., WVD2) without stringent validation .

  • Sample Preparation: Heat-mediated antigen retrieval (citrate buffer, pH 6) improves IHC results .

  • Lot Consistency: Recombinant secondary antibodies (e.g., Superclonal™) ensure reproducibility in blotting .

Future Directions

  • CRISPR/Cas9-GFP Fusion: Tagging WDL1 for live-cell imaging.

  • Therapeutic Exploration: Though WDL1 is plant-specific, insights into its structure may inform animal cell expansion studies .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
WDL1 antibody; At3g04630 antibody; F7O18.11 antibody; Protein WVD2-like 1 antibody; AtWDL1 antibody
Target Names
WDL1
Uniprot No.

Target Background

Function
WDL1 is a microtubule-associated protein (MAP) that regulates the orientation of cortical microtubules during interphase. It modulates both rotational polarity and anisotropic cell expansion during organ growth. Specifically, WDL1 promotes clockwise coiling in roots and etiolated hypocotyls, clockwise leaf curling, and left-handed petiole twisting.
Database Links

KEGG: ath:AT3G04630

STRING: 3702.AT3G04630.1

UniGene: At.40803

Protein Families
TPX2 family
Subcellular Location
Cytoplasm, cytoskeleton.

Q&A

What is WDL1 and why is it significant in plant developmental research?

WDL1 (WVD2-Like1) is a protein encoded by the At3g04630 gene in Arabidopsis thaliana that functions as a regulator of rotational polarity and anisotropic cell expansion during organ growth . It belongs to a family of proteins that share sequence similarity, particularly in the KLEEK domain region. Research indicates that WDL1 is significant because its overexpression results in altered root growth phenotypes, including shorter roots that don't wave and slant to the left on tilted agar surfaces, demonstrating its crucial role in plant morphogenesis .

What are the typical applications for WDL1 antibodies in plant research?

WDL1 antibodies serve several critical research applications:

  • Immunolocalization studies to determine subcellular distribution patterns

  • Western blotting for protein expression analysis across different tissues

  • Co-immunoprecipitation to identify protein interaction partners

  • Chromatin immunoprecipitation if nuclear associations are suspected

  • Immunohistochemistry to visualize tissue-specific expression patterns

When designing experiments with WDL1 antibodies, researchers should consider the broad expression pattern of WDL1 across multiple plant tissues, including seedlings, roots, flowers, rosette leaves, siliques, and inflorescence stems .

What are the optimal sample preparation methods for WDL1 immunodetection?

For effective WDL1 immunodetection:

  • Tissue fixation:

    • For immunolocalization: Use 4% paraformaldehyde in phosphate buffer

    • For whole-mount samples: Include 0.1-0.5% Triton X-100 to improve antibody penetration

  • Antigen retrieval:

    • Mild heat treatment (80°C for 10 minutes) in citrate buffer (pH 6.0)

    • Enzymatic treatment with proteinase K may improve epitope accessibility

  • Blocking conditions:

    • Use 3-5% BSA or normal serum in PBS with 0.1% Triton X-100

    • Extended blocking (2-3 hours at room temperature) reduces background

The detection protocol should be optimized considering that WDL1 is expressed in multiple tissues but may have different expression levels across developmental stages .

How should WDL1 antibody specificity be validated?

A comprehensive validation approach includes:

Validation MethodImplementationExpected Outcome
Genetic controlsTest antibody in wild-type vs. wdl1 knockout plantsSignal present in wild-type, absent/reduced in knockout
Overexpression linesTest in 35S:WDL1 transgenic plantsEnhanced signal correlating with expression level
Peptide competitionPre-incubate antibody with immunizing peptideDiminished or eliminated signal
Cross-reactivity assessmentTest against WVD2 and other family membersMinimal reactivity with other proteins
Western blotConfirm band at expected molecular weight (32 kDa)Single band at correct size

This validation is particularly important given the similarity between WDL1 and WVD2 (59.9% identity), which could lead to cross-reactivity issues .

What protocols are recommended for studying WDL1 and microtubule interactions?

Since WDL1 affects anisotropic cell expansion, investigating its relationship with microtubules is crucial:

  • Co-localization studies:

    • Double immunolabeling with anti-WDL1 and anti-tubulin antibodies

    • Confocal microscopy with appropriate controls for cross-reactivity

    • Super-resolution microscopy for detailed subcellular localization

  • Drug treatments:

    • Apply microtubule-disrupting agents (oryzalin, taxol)

    • Compare WDL1 localization before and after treatment

    • Assess phenotypic changes in WDL1 overexpression lines following treatment

  • Live cell imaging:

    • Combine antibody data with WDL1-GFP fusion protein localization

    • Time-lapse imaging during cell expansion and division

This approach is supported by observations that WDL1 expression affects cell expansion patterns that are typically regulated by cortical microtubules .

How can WDL1 antibodies be used to study protein-protein interactions?

For investigating WDL1 interaction networks:

  • Co-immunoprecipitation (Co-IP):

    • Use anti-WDL1 antibodies conjugated to sepharose or magnetic beads

    • Perform pull-downs from plant extracts under native conditions

    • Identify binding partners through mass spectrometry analysis

  • Proximity-dependent labeling:

    • Generate WDL1 fusions with promiscuous biotin ligases

    • Use WDL1 antibodies to validate expression and localization

    • Identify biotinylated proximal proteins

  • Yeast two-hybrid validation:

    • Confirm interactions identified from Co-IP experiments

    • Use WDL1 antibodies to validate expression levels in plant systems

This is particularly relevant given that WDL1's function in modulating cell expansion likely involves interactions with cytoskeletal components and cell wall modification enzymes .

What approaches enable quantitative analysis of WDL1 expression across developmental stages?

For quantitative assessment of WDL1 protein levels:

TechniqueApplicationQuantification Method
Western blottingBulk tissue analysisDensitometry against standard curve
ELISAQuantitative expressionAbsorbance measurements with purified standards
ImmunohistochemistryTissue-specific expressionFluorescence intensity measurement
Flow cytometryCell-type specific analysisMean fluorescence intensity
Mass spectrometryAbsolute quantificationSelected reaction monitoring with isotope-labeled standards

These quantitative approaches can reveal how WDL1 expression correlates with observed phenotypes in different genetic backgrounds and developmental contexts .

How can researchers investigate WDL1's role in directional cell growth using antibodies?

To study WDL1's involvement in directional growth:

  • Immunolocalization during gravitropic responses:

    • Track WDL1 distribution before and after gravistimulation

    • Compare localization patterns in upper vs. lower sides of responding organs

    • Correlate WDL1 distribution with asymmetric cell expansion

  • Mechanical stimulation experiments:

    • Apply controlled mechanical stress to seedlings

    • Use immunolocalization to detect WDL1 redistribution

    • Link to phenotypic observations in wdl1 mutants and overexpression lines

  • Cell-specific expression analysis:

    • Use laser capture microdissection combined with immunoblotting

    • Compare WDL1 levels in cells exhibiting different growth directions

This approach is supported by observations that WDL1 overexpression affects root slanting and helical growth patterns .

What are common challenges when using WDL1 antibodies, and how can they be addressed?

Common technical issues include:

ChallengeProbable CauseSolution
High backgroundNon-specific bindingIncrease blocking time (3-16 hours); try different blocking agents
Weak signalLimited antibody accessOptimize antigen retrieval; increase incubation time
Multiple bandsCross-reactivityUse peptide competition; increase washing stringency
Inconsistent resultsExpression variabilityStandardize growth conditions and harvest timing
No signalEpitope maskingTry multiple antibodies targeting different regions

When optimizing WDL1 immunodetection protocols, researchers should consider that WDL1 is expressed in multiple tissues but may have tissue-specific interaction partners that could affect epitope accessibility .

How can researchers differentiate between WDL1 and its homolog WVD2 using antibodies?

Given the 59.9% amino acid identity between WDL1 and WVD2, differentiation requires:

  • Epitope selection:

    • Design peptide antibodies against regions with lowest sequence similarity

    • Avoid the conserved KLEEK domain shared among family members

  • Validation strategy:

    • Test antibodies on tissues from wdl1 and wvd2 single mutants

    • Use double mutants as negative controls

    • Perform Western blotting to distinguish based on slight molecular weight differences

  • Competitive assays:

    • Pre-absorb antibodies with recombinant WDL1 or WVD2

    • Test resulting specificity on known expressing tissues

This differentiation is crucial as both proteins affect similar developmental processes but may have distinct molecular functions .

How do WDL1 protein levels correlate with phenotypic severity in transgenic lines?

Research indicates a dose-dependent relationship between WDL1 expression and phenotypic effects:

Expression LevelRoot PhenotypeShoot Phenotype
Wild-typeNormal waving, right-slantingNormal leaf arrangement
Heterozygous wvd2-1Intermediate waving, variable slantingMild leaf curling
Homozygous wvd2-1/35S:WDL1No waving, left-slantingPronounced clockwise leaf curling

These observations suggest that precise regulation of WDL1 levels is critical for normal plant development, with higher expression levels progressively altering growth directionality and cell expansion patterns .

What is known about WDL1 post-translational modifications?

While specific data on WDL1 post-translational modifications remains limited, researchers can investigate:

  • Phosphorylation:

    • Generate phospho-specific antibodies targeting predicted sites

    • Compare electrophoretic mobility in control vs. phosphatase-treated samples

    • Correlate phosphorylation state with protein activity and localization

  • Other modifications:

    • Use immunoprecipitation followed by mass spectrometry

    • Compare modification patterns in different developmental contexts

    • Assess how modifications affect protein-protein interactions

Understanding these modifications could provide insights into how WDL1 activity is regulated in response to developmental and environmental cues.

What emerging technologies can enhance WDL1 antibody-based research?

Advanced approaches for future WDL1 research include:

  • Super-resolution microscopy:

    • STORM/PALM techniques for nanoscale localization

    • Multi-color imaging to visualize WDL1 interactions with cytoskeletal elements

  • Proximity labeling:

    • BioID or APEX2 fusions expressed in plants

    • Validate with conventional antibody approaches

    • Map the WDL1 protein interaction network with spatial resolution

  • Single-cell proteomics:

    • Combine with WDL1 antibodies for cell-type specific analysis

    • Correlate with transcriptomic data for comprehensive understanding

These approaches will help resolve the molecular mechanisms by which WDL1 influences plant cell growth directionality and organ development .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.